Cogitativo
Cogitativo specializes in AI-enabled precision health, focusing on improving patient outcomes through personalized insights and addressing chronic conditions.
Company Overview
Cogitativo is an AI-enabled precision health company headquartered at 2001 Addison St Suite 300, Berkeley, CA 94704. The company focuses on understanding the complexities of the human body influenced by behavioral, environmental, and genetic factors. Their goal is to improve patient outcomes and the value of care through personalized, actionable insights. Cogitativo specifically addresses chronic conditions, which account for 90% of healthcare costs.
AI Precision Health Platforms
Cogitativo utilizes two key platforms: Visi�n and Ventanas. The Visi�n platform is notable for being the first machine learning platform in the market that predicts multiple clinical endpoints and identifies clinically vulnerable patients. On the other hand, the Ventanas platform focuses on optimizing health plan effectiveness and operational awareness. It aims to address critical challenges faced by payors in the healthcare industry.
Financial Backing
Cogitativo has successfully raised significant funding to support its initiatives. In September 2017, the company raised $5 million in Series A financing. This was followed by a Series B round of financing in December 2019, where Cogitativo secured an additional $18.5 million. These funds have contributed to the development and enhancement of their AI-enabled precision health solutions.
Health Solutions and Impact
Cogitativo offers various solutions designed to identify clinically vulnerable individuals, predict the progression of chronic diseases, and measure the impact of medical interventions. These solutions are aimed at improving overall patient outcomes and increasing the value of healthcare provided. The company leverages advanced AI technology to provide healthcare providers with actionable insights that can lead to better management of chronic conditions.